From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

On November 5, the Federal Trade Commission (“FTC”) filed a complaint against a company in connection with its mobile banking ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Fortunately, since my diagnosis of Sjogren's disease, there have been important efforts to rein in these middlemen who drive up costs for ... insurance companies manage claims and lower patient drug ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is ...

It is all over bar the shouting win for the US election, with Donald Trump set to claim the Presidency, potentially with the ...

For example, the big-three PBMs are the dominant middlemen in drug transactions, and they’re each part of ... Those actions ...